831 related articles for article (PubMed ID: 32653382)
1. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
[TBL] [Abstract][Full Text] [Related]
2. Potential Role of the Renal Arterial Resistance Index in the Differential Diagnosis of Diabetic Kidney Disease.
Li H; Shen Y; Yu Z; Huang Y; He T; Xiao T; Li Y; Xiong J; Zhao J
Front Endocrinol (Lausanne); 2021; 12():731187. PubMed ID: 35095752
[TBL] [Abstract][Full Text] [Related]
3. Urinary Neutrophil Gelatinase-Associated Lipocalin Is Complementary to Albuminuria in Diagnosis of Early-Stage Diabetic Kidney Disease in Type 2 Diabetes.
Gala-Błądzińska A; Dumnicka P; Kuśnierz-Cabala B; Rybak K; Drożdż R; Żyłka A; Kuźniewski M
Biomed Res Int; 2017; 2017():4691389. PubMed ID: 28845433
[TBL] [Abstract][Full Text] [Related]
4. Is Urinary NGAL Determination Useful for Monitoring Kidney Function and Assessment of Cardiovascular Disease? A 12-Month Observation of Patients with Type 2 Diabetes.
Żyłka A; Gala-Błądzińska A; Dumnicka P; Ceranowicz P; Kuźniewski M; Gil K; Olszanecki R; Kuśnierz-Cabala B
Dis Markers; 2016; 2016():8489543. PubMed ID: 28050059
[No Abstract] [Full Text] [Related]
5. Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy.
Wei J; Wang B; Shen FJ; Zhang TT; Duan Z; Zhou DM
BMC Nephrol; 2022 Jul; 23(1):270. PubMed ID: 35896961
[TBL] [Abstract][Full Text] [Related]
6. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H
Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550
[TBL] [Abstract][Full Text] [Related]
7. Utilization of the corticomedullary difference in magnetic resonance imaging-derived apparent diffusion coefficient for noninvasive assessment of chronic kidney disease in type 2 diabetes.
Duan S; Geng L; Lu F; Chen C; Jiang L; Chen S; Zhang C; Huang Z; Zeng M; Sun B; Zhang B; Mao H; Xing C; Zhang Y; Yuan Y
Diabetes Metab Syndr; 2024 Feb; 18(2):102963. PubMed ID: 38373384
[TBL] [Abstract][Full Text] [Related]
8. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
9. Urinary neutrophil gelatinase-associated lipocalin in dogs with stable or progressive kidney disease.
Kim YM; Polzin DJ; Rendahl A; Granick JL
J Vet Intern Med; 2019 Mar; 33(2):654-661. PubMed ID: 30767290
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil Gelatinase-Associated Lipocalin in Cats with Naturally Occurring Chronic Kidney Disease.
Wang IC; Hsu WL; Wu PH; Yin HY; Tsai HJ; Lee YJ
J Vet Intern Med; 2017 Jan; 31(1):102-108. PubMed ID: 28019047
[TBL] [Abstract][Full Text] [Related]
11. Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study.
Zeng XF; Lu DX; Li JM; Tan Y; Li Z; Zhou L; Xi ZQ; Zhang SM; Duan W
BMC Nephrol; 2017 Jul; 18(1):233. PubMed ID: 28701152
[TBL] [Abstract][Full Text] [Related]
12. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
Front Immunol; 2020; 11():2073. PubMed ID: 32983156
[No Abstract] [Full Text] [Related]
13. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
[TBL] [Abstract][Full Text] [Related]
14. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
[TBL] [Abstract][Full Text] [Related]
15. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
[TBL] [Abstract][Full Text] [Related]
16. Urinary NGAL and RBP Are Biomarkers of Normoalbuminuric Renal Insufficiency in Type 2 Diabetes Mellitus.
Li A; Yi B; Liu Y; Wang J; Dai Q; Huang Y; Li YC; Zhang H
J Immunol Res; 2019; 2019():5063089. PubMed ID: 31637265
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of non-diabetic kidney disease and inability of clinical predictors to differentiate it from diabetic kidney disease: results from a prospectively performed renal biopsy study.
Basu M; Pulai S; Neogi S; Banerjee M; Bhattacharyya NP; Sengupta S; Mukhopadhyay P; Ray Chaudhury A; Ghosh S
BMJ Open Diabetes Res Care; 2022 Dec; 10(6):. PubMed ID: 36517108
[TBL] [Abstract][Full Text] [Related]
18. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.
de Carvalho JA; Tatsch E; Hausen BS; Bollick YS; Moretto MB; Duarte T; Duarte MM; Londero SW; Premaor MO; Comim FV; Delanghe JR; Moresco RN
Clin Biochem; 2016 Feb; 49(3):232-6. PubMed ID: 26519090
[TBL] [Abstract][Full Text] [Related]
19. Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021.
Zeng YQ; Yang YX; Guan CJ; Guo ZW; Li B; Yu HY; Chen RX; Tang YQ; Yan R
BMC Endocr Disord; 2022 Jun; 22(1):168. PubMed ID: 35773653
[TBL] [Abstract][Full Text] [Related]
20. Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study.
Chen S; Chen L; Jiang H
Ren Fail; 2022 Dec; 44(1):1309-1318. PubMed ID: 35938702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
